Identification of conserved RNA secondary structures in human respiratory syncytial virus A (hRSV A). [PDF]
Dabiri DK, Rouse WB, Moss WN.
europepmc +1 more source
Real-world effectiveness of nirsevimab against respiratory syncytial virus in pediatric practice: the Piemonitorab study. [PDF]
Funiciello E +8 more
europepmc +1 more source
Clesrovimab for the Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants. [PDF]
Phillips B, Jackson C, Phillips J.
europepmc +1 more source
Economic Burden of Respiratory Syncytial Virus Infection in Colombia: A Nationwide Cost-of-Illness Study. [PDF]
Buitrago G +7 more
europepmc +1 more source
Nirsevimab Prophylaxis and Respiratory Syncytial Virus Hospitalizations Among Infants.
Cocchi E +13 more
europepmc +1 more source
Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants. [PDF]
Rodriguez-Martinez CE +12 more
europepmc +1 more source
Urban contact patterns shape respiratory syncytial virus epidemics with implications for vaccination. [PDF]
Kimball P +5 more
europepmc +1 more source
Transcriptomic profiling reveals Trichinella spiralis-mediated attenuation of respiratory syncytial virus-induced inflammation in mice. [PDF]
Chu KB, Quan FS.
europepmc +1 more source
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection. [PDF]
Pernikoff S +12 more
europepmc +1 more source

